J Psychiatr Pract 2018 Jan;24(1):2-14
BARTERIAN: Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH SANCHEZ: The Right Door for Hope, Recovery and Wellness, Ionia, MI, and Wedgwood Christian Services, Grand Rapids, MI MAGEN: Department of Psychiatry, Michigan State University, East Lansing, MI SIROKY and CARLSON: Department of Counseling, Educational Psychology, & Special Education, Michigan State University, East Lansing, MI MASH: Howell, MI.
This study examined the utility of fluoxetine in the treatment of 5 children, aged 5 to 14 years, diagnosed with selective mutism who also demonstrated symptoms of social anxiety. A nonconcurrent, randomized, multiple-baseline, single-case design with a single-blind placebo-controlled procedure was used. Parents and the study psychiatrist completed multiple methods of assessment including Direct Behavior Ratings and questionnaires. Read More